Monster Beverage (MNST) CSO reports new stock, RSU and option awards

Rhea-AI Filing Summary

Monster Beverage Corp Chief Strategy Officer Emelie Tirre reported multiple equity compensation transactions. On March 13, she received 27,200 shares of common stock, 3,900 restricted stock units and 11,700 employee stock options with an exercise price of $77.11 per share expiring in 2036. Over March 12–14, vested restricted stock units were exercised into common stock, and shares were withheld to cover tax liabilities at prices around $77 per share, recorded as dispositions but not open‑market sales. Following these transactions, she directly owns 81,763 shares of Monster Beverage common stock and holds additional vested and unvested stock options with exercise prices between $36.62 and $60.30 expiring from 2031 to 2035.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tirre Emelie

(Last) (First) (Middle)

1 MONSTER WAY

(Street)

CORONA CA 92879

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Monster Beverage Corp [ MNST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Strategy Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		M		1,680	A	(1)	65,619	D
Common Stock	03/12/2026		F		855	D	$76.99	64,764	D
Common Stock	03/13/2026		A(2)		27,200	A	$0	91,964	D
Common Stock	03/13/2026		F		13,840	D	$77.11	78,124	D
Common Stock	03/14/2026		M		3,400	A	(1)	81,524	D
Common Stock	03/14/2026		M		1,360	A	(1)	82,884	D
Common Stock	03/14/2026		M		900	A	(1)	83,784	D
Common Stock	03/14/2026		M		1,750	A	(1)	85,534	D
Common Stock	03/14/2026		F		3,771	D	$77.05	81,763	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$44.47							(3)	03/12/2031	Common Stock	(4)		20,000	D
Employee Stock Option (right to buy)	$36.62							(5)	03/14/2032	Common Stock	(4)		46,000	D
Employee Stock Option (right to buy)	$50.82							(6)	03/14/2033	Common Stock	(4)		19,998	D
Employee Stock Option (right to buy)	$50.82							(3)	03/14/2033	Common Stock	(4)		20,000	D
Employee Stock Option (right to buy)	$60.3							(7)	03/14/2034	Common Stock	(4)		18,000	D
Employee Stock Option (right to buy)	$55.09							(8)	03/14/2035	Common Stock	(4)		21,000	D
Employee Stock Option (right to buy)	$77.11	03/13/2026		A		11,700		(9)	03/13/2036	Common Stock	11,700	$0	11,700	D
Restricted Stock Units	(10)	03/12/2026		M			1,680	(11)	(12)	Common Stock	1,680	$0	0	D
Restricted Stock Units	(10)	03/14/2026		M			3,400	(13)	(12)	Common Stock	3,400	$0	4,080	D
Restricted Stock Units	(10)	03/14/2026		M			1,360	(14)	(12)	Common Stock	1,360	$0	3,740	D
Restricted Stock Units	(10)	03/14/2026		M			900	(15)	(12)	Common Stock	900	$0	4,500	D
Restricted Stock Units	(10)	03/14/2026		M			1,750	(16)	(12)	Common Stock	1,750	$0	5,250	D
Restricted Stock Units	(10)	03/13/2026		A		3,900		(17)	(12)	Common Stock	3,900	$0	3,900	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date. Accordingly, these restricted stock units were settled in shares of common stock.

2. Received upon the achievement of the vesting criteria applicable to performance share units granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan (the "2020 Omnibus Incentive Plan"), achievement of which was certified by the Compensation Committee of the Company's Board of Directors. Each performance share unit represents a contingent right to receive one share of the Company's common stock as of the applicable vesting date.

3. The options are currently vested.

4. No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.

5. The options are currently vested with respect to 32,200 shares. The remaining options vest on March 14, 2027.

6. Due to a scrivener's error in the Reporting Person's Form 4, filed on December 16, 2025, the corresponding footnote incorrectly reported that 5,000 options were currently vested, which number should have been 4,998 shares. The options are currently vested with respect to 8,998 shares. The remaining options vest in two installments as follows: 5,000 shares on March 14, 2027 and 6,000 shares on March 14, 2028.

7. The options are currently vested with respect to 4,500 shares. The remaining options vest in three installments as follows: 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028 and 5,400 shares on March 14, 2029.

8. The options are currently vested with respect to 5,250 shares. The remaining options vest in three equal installments on March 14, 2027, March 14, 2028 and March 14, 2029.

9. The options vest in three equal installments on March 13, 2027, March 13, 2028 and March 13, 2029.

10. The restricted stock units were granted under the 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.

11. The restricted stock units are fully vested.

12. Not applicable.

13. The remaining restricted stock units vest on March 14, 2027.

14. The remaining restricted stock units vest in two installments as follows: 1,700 units on March 14, 2027 and 2,040 units on March 14, 2028.

15. The remaining restricted stock units vest in three installments as follows: 1,200 units on March 14, 2027; 1,500 units on March 14, 2028 and 1,800 units on March 14, 2029.

16. The remaining restricted stock units vest in three equal installments on March 14, 2027, March 14, 2028 and March 14, 2029.

17. The restricted stock units vest in three equal installments on March 13, 2027, March 13, 2028 and March 13, 2029.

	Paul J. Dechary, attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MNST Chief Strategy Officer Emelie Tirre report?

Emelie Tirre reported equity compensation grants and related vesting activity. She received common stock, restricted stock units, and stock options, then exercised vested RSUs into common shares, with a portion of shares withheld to cover tax obligations rather than sold in the open market.

How many Monster Beverage (MNST) shares does Emelie Tirre own after these Form 4 transactions?

After the reported transactions, Emelie Tirre directly owns 81,763 MNST shares. This figure reflects equity grants, RSU exercises and share withholdings for taxes during March 12–14, 2026, as disclosed in the Form 4 filing for Monster Beverage Corp.

What stock option grant did Emelie Tirre receive from Monster Beverage in March 2026?

She received 11,700 employee stock options on March 13, 2026. These options allow her to buy Monster Beverage common stock at an exercise price of $77.11 per share and are scheduled to expire in 2036, according to the Form 4 disclosure.

Were there any open-market buys or sells by MNST’s Emelie Tirre in this Form 4?

The filing shows no open-market purchases or sales. Reported acquisitions come from equity grants and RSU exercises, while dispositions are tax-withholding transactions, where shares are surrendered to satisfy tax liabilities instead of being sold on the open market.

What restricted stock unit activity did Monster Beverage report for Emelie Tirre?

Tirre both received and settled restricted stock units. She was granted 3,900 RSUs on March 13, 2026, and separate RSU awards vested and were converted into common shares on March 12 and March 14, consistent with the company’s 2020 Omnibus Incentive Plan documentation.

Does Emelie Tirre still hold Monster Beverage stock options after these transactions?

Yes, she continues to hold multiple stock option positions. Remaining options have exercise prices ranging from $36.62 to $60.30 per share, with expirations between 2031 and 2035, as listed in the derivative holdings section of the Form 4.